Login / Signup

The ERA-EDTA Registry Annual Report 2018: a summary.

Anneke KramerRianne BoeninkVianda S StelCarmen Santiuste de PablosFilip TomovićEliezer GolanJulia KerschbaumNurhan SeyahiKyriakos IoanouPalma BeltránOscar ZurriagaÁngela MagazMaría F Slon RobleroNikola GjorgjievskiLiliana GarneataFederico ArribasAna A GalvãoSamira BellMai Ots-RosenbergJosé M Muñoz-TerolRebecca WinzelerKristine HommelAnders ÅsbergViera SpustovaMaría Ángeles Palencia GarcíaEvgueniy VazelovPatrik FinneMarc A G J Ten DamFrantišek LopotSara Trujillo-AlemánMathilde LassalleMykola O KolesnykShalini SanthakumaranAlma IdriziAnton AndrusevJordi Comas FarnésKirill KomissarovHalima ResićRunolfur PalssonViktorija KuzemaMaria Angeles Garcia BazagaEdita ZiginskieneMaria StendahlMarjolein BonthuisZiad A MassyKitty J Jager
Published in: Clinical kidney journal (2020)
In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
Keyphrases